We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCBI:NASDAQTexas Capital Bancshares, Inc. Analysis

Data as of 2026-05-28 - not real-time

$98.14

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Texas Capital Bancshares posted a 15.5% revenue increase year‑over‑year to $324 million and a non‑GAAP EPS of $1.58, topping consensus by 12.4%, underscoring the momentum highlighted in the recent earnings beat. Operating margins sit at 32% and net profit margins at 28.7%, reflecting strong profitability for a regional bank. The stock trades at a forward P/E of 11.7, well below the industry average of 16.6, while the price‑to‑book ratio of 1.30 suggests a modest premium to book value. Technicals are supportive: the price of $98.14 is above the 200‑day SMA ($92.75) and the MACD histogram is positive, indicating a bullish tilt despite a neutral RSI of 47.5. Support sits at $94.06 with resistance near $103.29, offering a clear upside corridor, and the 30‑day volatility of 25% is manageable given the company’s strong balance sheet (cash $2.93 bn vs debt $0.92 bn).
The DCF‑derived fair value of $235.33 implies a substantial undervaluation, and the modest 0.8% dividend appears sustainable given the net‑cash position and zero payout ratio. Market sentiment is extremely bullish (Fear‑Greed Index 92), yet the stock’s beta (~1.2) and stable volume suggest that price swings will be contained, making TCBI an attractive entry for investors seeking a blend of growth and value in the regional banking sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Q1 earnings beat and 15.5% revenue growth
  • Bullish MACD signal and price above 200‑day SMA
  • Upside potential to $103.29 resistance level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE ratio of 13.2 versus industry 16.6 indicating valuation discount
  • Strong cash position ($2.93 bn) versus modest debt ($0.92 bn)
  • Consistent dividend yield and sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value of $235.33 suggests long‑term upside
  • Stable operating margins and solid ROE (~10%)
  • Strategic leadership appointments supporting growth trajectory

Key Metrics & Analysis

Financial Health

Revenue Growth16.90%
Profit Margin28.67%
P/E Ratio13.2
ROE10.15%
ROA1.10%
P/B Ratio1.3
Op. Cash Flow$447.3M
Industry P/E16.6

Technical Analysis

TrendBullish
RSI47.5
Support$94.06
Resistance$103.29
MA 20$98.91
MA 50$98.48
MA 200$92.75
MACDBullish
VolumeStable
Fear & Greed Index92.34

Valuation

Fair Value$235.33
Target Price$107.69
Upside/Downside9.73%
GradeUndervalued
TypeBlend
Dividend Yield0.80%

Risk Assessment

Beta1.17
Volatility25.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.